Covid-19 vaccine Covaxin, said the Indian Embassy in Bahrain on Friday. “Bahrain’s National Health Regulatory Authority @NHRABahrain approves the emergency use of India’s indigenously developed Covid-19 vaccination, Covaxin by Bharat Biotech," the embassy said in a tweet.
Covaxin, an inactivated whole virus vaccine, recently received emergency use approval from the World Health Organization (WHO) for people aged 18 and above.
Earlier on 10 November, Hong Kong and Vietnam also joined the list of nations that have approved the jab. The Made in India vaccine has also received a nod from the US, UK, Switzerland. Covaxin efficacy An interim analysis of Covaxin's phase 3 trial data published in The Lancet has revealed that two doses of the